SOLDES
Jusqu'à -70% sur une sélection d'articles*
Pharmaco-Capitalism: The Financialization of Chronic Cellular Disease. Patents, Prescriptions, and the Profit Motive in the Modern Medical Industry
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- Nombre de pages160
- FormatePub
- ISBN978-3-565-41726-1
- EAN9783565417261
- Date de parution18/04/2026
- Protection num.pas de protection
- Taille762 Ko
- Infos supplémentairesepub
- ÉditeurEmphaloz Publishing House
Résumé
The publicly stated mission of the modern pharmaceutical industry is to relentlessly cure disease and alleviate human suffering. However, its underlying financial architecture actively demands the exact opposite. From a strictly economic perspective, curing a patient permanently eradicates a reliable, paying customer. Consequently, the world's most powerful medical conglomerates have aggressively shifted their multi-billion-dollar research and development pipelines away from absolute cures and toward the highly lucrative, lifelong management of chronic symptoms.
Pharmaco-Capitalism deconstructs the ruthless financialization of the human body.
You will navigate the obscure, highly aggressive patent strategies used to artificially extend monopolies on essential insulins and biologics, effectively pricing millions out of survival. This system does not prioritize biological innovation; it prioritizes the mathematical extraction of wealth from sickness, transforming patients into perpetual subscription models for synthesized chemical interventions. Dismantle the economic illusions of the global healthcare sector.
Understand the deep, systemic conflicts of interest driving modern medical research, and explore the profound macroeconomic consequences of allowing private equity to completely dictate the boundaries of human longevity and wellness.
You will navigate the obscure, highly aggressive patent strategies used to artificially extend monopolies on essential insulins and biologics, effectively pricing millions out of survival. This system does not prioritize biological innovation; it prioritizes the mathematical extraction of wealth from sickness, transforming patients into perpetual subscription models for synthesized chemical interventions. Dismantle the economic illusions of the global healthcare sector.
Understand the deep, systemic conflicts of interest driving modern medical research, and explore the profound macroeconomic consequences of allowing private equity to completely dictate the boundaries of human longevity and wellness.